Compounded Heparin Sodium Recall Issued Due To Lack Of Preservatives, Infant Death Risk
A compounded heparin sodium recall announced by the FDA warns that certain lots may contain preservatives which could put newborn lives at risk.
Tag Archives: Heparin Recall
-
-
Bill to Create Drug Tracking System Passes House
Lawmakers moved closer this week to creating a new program that will track all drug prescriptions in the United States, hoping to reduce the risks associated with stolen or counterfeit…
-
Senators Propose New Drug Tracking Safety Bill
A bipartisan group of U.S. senators have proposed a new bill that would create a national drug tracking system to fight stolen, counterfeit and potentially harmful drugs.
-
Heparin Label Update Aims to Clarify Dosage Strength
Federal drug regulators have ordered a warning label update for the blood thinner heparin, which is designed to better explain the drug’s dosage strengths.
-
FDA Guidance Seeks to Eliminate Heparin Contamination Risk
Federal health regulators have drafted new industry guidelines that are designed to ensure the quality of heparin following the deaths of nearly 150 people several years ago when contaminated batches…
-
Unsolved Heparin Contamination Subject of Congressional Investigation
U.S. lawmakers are requesting a host of documents from a number of pharmaceutical companies in an attempt to track down the source of contamination in the blood thinner heparin, which…
-
Heparin Recall Lawsuit Ends in $625K Award in First of Hundreds of Claims
The family of an Illinois man was awarded $625,000 by a Cook County jury in the first of hundreds of lawsuits over Baxter heparin that was recalled several years ago…
-
Partial Summary Judgment Granted in Baxter Heparin Lawsuit
An Illinois judge has determined that the contaminated heparin imported into the United States by Baxter International, Inc. in late 2007 and early 2008 was “unreasonably dangerous,” granting partial summary…
-
Hylenex Recall: Baby Rehydration Fluids Contaminated with Glass Flakes
Baxter International Inc. is recalling about 3,200 vials of Hylenex, a pediatric rehydration medication, due to glass flake contamination. Halozyme Therapeutics, a company partnered with Baxter to manufacture Hylenex, has…
-
FDA Failed to Follow Credible Leads Involving Contaminated Heparin: Report
Two U.S. lawmakers say that FDA investigators failed to properly follow up on the source of contaminated heparin that caused severe allergic-type reactions in hundreds of people in late 2007…
